240 related articles for article (PubMed ID: 33120241)
21. Whole-brain amide proton transfer (APT) and nuclear overhauser enhancement (NOE) imaging in glioma patients using low-power steady-state pulsed chemical exchange saturation transfer (CEST) imaging at 7T.
Heo HY; Jones CK; Hua J; Yadav N; Agarwal S; Zhou J; van Zijl PC; Pillai JJ
J Magn Reson Imaging; 2016 Jul; 44(1):41-50. PubMed ID: 26663561
[TBL] [Abstract][Full Text] [Related]
22. Grading of Gliomas by Using Radiomic Features on Multiple Magnetic Resonance Imaging (MRI) Sequences.
Qin JB; Liu Z; Zhang H; Shen C; Wang XC; Tan Y; Wang S; Wu XF; Tian J
Med Sci Monit; 2017 May; 23():2168-2178. PubMed ID: 28478462
[TBL] [Abstract][Full Text] [Related]
23. MR Imaging-derived Oxygen Metabolism and Neovascularization Characterization for Grading and IDH Gene Mutation Detection of Gliomas.
Stadlbauer A; Zimmermann M; Kitzwögerer M; Oberndorfer S; Rössler K; Dörfler A; Buchfelder M; Heinz G
Radiology; 2017 Jun; 283(3):799-809. PubMed ID: 27982759
[TBL] [Abstract][Full Text] [Related]
24. A three-component multi-b-value diffusion-weighted imaging might be a useful biomarker for detecting microstructural features in gliomas with differences in malignancy and IDH-1 mutation status.
Cao M; Wang X; Liu F; Xue K; Dai Y; Zhou Y
Eur Radiol; 2023 Apr; 33(4):2871-2880. PubMed ID: 36346441
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic performance between MR amide proton transfer (APT) and diffusion kurtosis imaging (DKI) in glioma grading and IDH mutation status prediction at 3 T.
Xu Z; Ke C; Liu J; Xu S; Han L; Yang Y; Qian L; Liu X; Zheng H; Lv X; Wu Y
Eur J Radiol; 2021 Jan; 134():109466. PubMed ID: 33307459
[TBL] [Abstract][Full Text] [Related]
26. Improved Differentiation of Low-Grade and High-Grade Gliomas and Detection of Tumor Proliferation Using APT Contrast Fitted from Z-Spectrum.
Zhang J; Zhu W; Tain R; Zhou XJ; Cai K
Mol Imaging Biol; 2018 Aug; 20(4):623-631. PubMed ID: 29313159
[TBL] [Abstract][Full Text] [Related]
27. Intergrating conventional MRI, texture analysis of dynamic contrast-enhanced MRI, and susceptibility weighted imaging for glioma grading.
Su CQ; Lu SS; Han QY; Zhou MD; Hong XN
Acta Radiol; 2019 Jun; 60(6):777-787. PubMed ID: 30244590
[TBL] [Abstract][Full Text] [Related]
28. Glioma grading using multiparametric MRI: head-to-head comparison among dynamic susceptibility contrast, dynamic contrast-enhancement, diffusion-weighted images, and MR spectroscopy.
Seo M; Choi Y; Soo Lee Y; Ahn KJ; Kim BS; Park JS; Jeon SS
Eur J Radiol; 2023 Aug; 165():110888. PubMed ID: 37257338
[TBL] [Abstract][Full Text] [Related]
29. Amide proton transfer imaging might predict survival and IDH mutation status in high-grade glioma.
Joo B; Han K; Ahn SS; Choi YS; Chang JH; Kang SG; Kim SH; Zhou J; Lee SK
Eur Radiol; 2019 Dec; 29(12):6643-6652. PubMed ID: 31175415
[TBL] [Abstract][Full Text] [Related]
30. Molecular MRI differentiation between primary central nervous system lymphomas and high-grade gliomas using endogenous protein-based amide proton transfer MR imaging at 3 Tesla.
Jiang S; Yu H; Wang X; Lu S; Li Y; Feng L; Zhang Y; Heo HY; Lee DH; Zhou J; Wen Z
Eur Radiol; 2016 Jan; 26(1):64-71. PubMed ID: 25925361
[TBL] [Abstract][Full Text] [Related]
31. The diagnostic value of intravoxel incoherent motion imaging in differentiating high-grade from low-grade gliomas: a systematic review and meta-analysis.
Luo H; He L; Cheng W; Gao S
Br J Radiol; 2021 May; 94(1121):20201321. PubMed ID: 33876653
[TBL] [Abstract][Full Text] [Related]
32. 3D Amide Proton Transfer-Weighted Imaging for Grading Glioma and Correlating IDH Mutation Status: Added Value to 3D Pseudocontinuous Arterial Spin Labelling Perfusion.
Hou H; Chen W; Diao Y; Wang Y; Zhang L; Wang L; Xu M; Yu J; Song T; Liu Y; Yuan Z
Mol Imaging Biol; 2023 Apr; 25(2):343-352. PubMed ID: 35962302
[TBL] [Abstract][Full Text] [Related]
33. Predicting IDH mutation status in grade II gliomas using amide proton transfer-weighted (APTw) MRI.
Jiang S; Zou T; Eberhart CG; Villalobos MAV; Heo HY; Zhang Y; Wang Y; Wang X; Yu H; Du Y; van Zijl PCM; Wen Z; Zhou J
Magn Reson Med; 2017 Sep; 78(3):1100-1109. PubMed ID: 28714279
[TBL] [Abstract][Full Text] [Related]
34. Amide proton transfer imaging of adult diffuse gliomas: correlation with histopathological grades.
Togao O; Yoshiura T; Keupp J; Hiwatashi A; Yamashita K; Kikuchi K; Suzuki Y; Suzuki SO; Iwaki T; Hata N; Mizoguchi M; Yoshimoto K; Sagiyama K; Takahashi M; Honda H
Neuro Oncol; 2014 Mar; 16(3):441-8. PubMed ID: 24305718
[TBL] [Abstract][Full Text] [Related]
35. Accuracy of ADC derived from DWI for differentiating high-grade from low-grade gliomas: Systematic review and meta-analysis.
Wang QP; Lei DQ; Yuan Y; Xiong NX
Medicine (Baltimore); 2020 Feb; 99(8):e19254. PubMed ID: 32080132
[TBL] [Abstract][Full Text] [Related]
36. Differentiation of recurrent diffuse glioma from treatment-induced change using amide proton transfer imaging: incremental value to diffusion and perfusion parameters.
Park YW; Ahn SS; Kim EH; Kang SG; Chang JH; Kim SH; Zhou J; Lee SK
Neuroradiology; 2021 Mar; 63(3):363-372. PubMed ID: 32879995
[TBL] [Abstract][Full Text] [Related]
37. Ki-67 labeling index and the grading of cerebral gliomas by using intravoxel incoherent motion diffusion-weighted imaging and three-dimensional arterial spin labeling magnetic resonance imaging.
Wang C; Dong H
Acta Radiol; 2020 Aug; 61(8):1057-1063. PubMed ID: 31830431
[TBL] [Abstract][Full Text] [Related]
38. Evaluating the Role of Amide Proton Transfer (APT)-Weighted Contrast, Optimized for Normalization and Region of Interest Selection, in Differentiation of Neoplastic and Infective Mass Lesions on 3T MRI.
Debnath A; Gupta RK; Singh A
Mol Imaging Biol; 2020 Apr; 22(2):384-396. PubMed ID: 31228076
[TBL] [Abstract][Full Text] [Related]
39. Comparative analysis of the diffusion kurtosis imaging and diffusion tensor imaging in grading gliomas, predicting tumour cell proliferation and IDH-1 gene mutation status.
Zhao J; Wang YL; Li XB; Hu MS; Li ZH; Song YK; Wang JY; Tian YS; Liu DW; Yan X; Jiang L; Yang ZY; Chu JP
J Neurooncol; 2019 Jan; 141(1):195-203. PubMed ID: 30414095
[TBL] [Abstract][Full Text] [Related]
40. The T2-FLAIR-mismatch sign as an imaging biomarker for IDH and 1p/19q status in diffuse low-grade gliomas: a systematic review with a Bayesian approach to evaluation of diagnostic test performance.
Goyal A; Yolcu YU; Goyal A; Kerezoudis P; Brown DA; Graffeo CS; Goncalves S; Burns TC; Parney IF
Neurosurg Focus; 2019 Dec; 47(6):E13. PubMed ID: 31786548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
